Presenters

Kemtai provides a B2B computer vision exercise platform that uses proprietary neural network algorithms to accurately analyze human motion and provide real-time corrective guidance to users and patients.

· Advanced computer vision technologies specifically developed for human motion tracking, digital assessments and corrective guidance

· Pure software solution that runs on any smartphone/tablet/desktop and requires no sensors or wearables

· Robust API framework and white labeling integration options.

CorNeat Vision developed the first and only biomimetic extracellular matrix, the CorNeat EverMatrix™, which seamlessly and permanently embeds with live tissue without triggering an inflammatory response. Its durability and flexibility, coupled with its bio-integration capabilities, mark a new era of implants that can:

· Bio-mechanically integrate with surrounding tissue

· Permanently reinforce soft tissue and accelerate its healing

· Act as a membrane for guided soft tissue and bone regeneration

· Conceal irritating implants

· Enable sensors to continuously remain in contact with surrounding tissue

Donisi is a MedTech company whose unique platform enables a preemptive approach, fulfilling unmet needs in home monitoring to save lives, reduce costs & improve Quality of Life for people with CHF and other chronic diseases.

Donisi has developed the only contactfree, clinically validated device for cardiac and respiratory assessment.

  • Backed by 11 registered patents

  • ISO 13485 certified

  • 1st Gen device FDA cleared via denovo pathway

  • 2nd Gen device Israeli Regulatory cleared

  • New bio-indicators like pulmonary congestion to be submitted to FDA via 510k pathway, based on our own predicate device

  • AFib was submitted we got some guidelines on how to proceed in the 510k process

Wisdo is a Social Health and clinical referral platform. We address the adverse financial and health costs of social isolation and loneliness affecting 111M Americans aged 17-85, costing health insurance plans and employers $161B.

Since 2010 Wisdo has become the most impactful, cost effective and evidence driven peer support and referral platform, through our work with health insurance plans, employers and government. Our results:

  • 58% reported lower rates of loneliness by day 90

  • 61% reported a decrease in unhealthy days after their first month on Wisdo, with an average decrease of 6.5 days

  • $900-$1020 cost reduction per member per year

  • 90% of people joining completed a “mapping out” of their main obstacles to health

  • 25% referral success rate of at-risk participants to teletherapy


BioLight Life Sciences Ltd is an Israeli investment group, publicly traded [TASE: BOLT] which focuses solely on Ophthalmology.

BioLight invested in 10 portfolio companies, developing drugs, devices, diagnostics and digital health products in Ophthalmology. BioLight currently holds 4 subsidiaries and 5 portfolio companies and one subsidiary was successfully sold.

BioT provides a validated platform for building Cloud-Native medical devices. These devices rely so heavily on the cloud that the cloud becomes part of the regulated scope. It usually takes years to build such systems... with BioT it takes a day. BioT powers the clouds of dozens of manufacturers, from big enterprises to startups, across many clinical domains - cardiovascular, neurology, orthopedics, and many more.

By revolutionizing the way biomarkers/drug targets are identified, validated, and implemented in the clinic (Accuracy & Speed), BiotaX enables new insights into disease development and creates new intervention models that were not known before.

Biotax has developed a novel computational platform that map the interaction of the immune system with the gut microbiota (Bactria, Fungi’s, Viruses) communities & their ecology functions.

Curesponse is a clinical/commercial stage start up, maker of the cResponse, an AI-driven, functional/genomics drug prioritization platform that accurately selects the most effective cancer treatment for each patient. The platform combines rapid next generation sequencing (NGS) with a proprietary functional response assay that assess the response of a cancerous tissue to various drug and drug combinations, while preserving functional Tumor Microenvironment (TME). This combination enables cResponse to be the only platform that can offer patients, oncologists, and pharma partners a truly empirical test that captures the sensitivity and resistance of an individual tumor to 10 different drugs/drug combinations within 2 weeks from biopsy/surgery, across the full therapeutic modality spectrum (chemo, biologics, IO).

Pepticom is a growth-stage company developing an AI-based novel-peptide-drug discovery and design platform, addressing the $50B peptide therapeutics market.

The company’s vision is to unlock the next generation of peptide therapeutics by

· Accelerating peptide-drug discovery

· Decreasing the cost

· Improve drug administration routes

· Expanding peptide-therapeutics modalities to generate a profound impact on patients' health and to find a cure for many of today’s untreated diseases.

Pepticom has shown unprecedented results taking a molecule from artificial design to successful POC in animals, and proudly announced the first AI-based peptide drug candidate in the world to treat Psoriasis.

Go Innovation is a unique LiveScience incubator that identifies innovators and early-stage startups with disruptive technologies that will shape the future of the Healthcare Industry. GO fund & Incubator enables startups to accelerate R&D, validation, and time to market while helping them grow to meet their potential.

GO currently manage 12 portfolio

companies, developing medical devices & diagnostics, digital health products, Functional Food, FoodTech biotechnology, and AgTech companies.

TestDynamics has a unique platform that connects many artificial intelligence (AI) algorithms with healthcare providers. We simplify installation, workflow, and billing, while enhancing choice.

We dream of a world where the best AI, as defined by the physician, can be applied to any indication, thereby creating an indispensable tool for the best patient care.

The company is committed to the development of first-in-class effective therapies by harnessing the power of the tumor microenvironment (TME) to overcome drug resistance and improve treatment outcome for cancer patients.

Intuition Robotics is reducing loneliness and empowering older adults to maintain their independence through their award-winning robotic companion device, ElliQ.

ElliQ is a proactive, voice operated device that uses empathetic AI to engage seniors throughout the day. Offering entertainment and companionship, connection to loved ones, health and wellness support, and more, ElliQ is proven to reduce loneliness by 80%.

ExoProTher Medical is an Israeli biotech company, developing a breakthrough bio-therapy that targets 60% of human cancers. The company has achieved strong positive results in pre-clinical trials with no adverse effects.

Commercially active since 2018, post revenue, with +40K users and +20 paying healthcare facilities. Team size – 16. Raised $5M. HQ in Israel with commercial operation center in NYC and operations in NY, NJ, NC, NV. Soapy is an AI-powered company that provides infection prevention technologies to hospitals and healthcare facilities. Patented technology with proven results in reducing Hospital Acquired Infections (HAIs). Soapy improves hand hygiene adherence and hand hygiene quality all while reducing running costs and reducing liability and the risk of lawsuits.